Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Genincode PLC
GENICurrent price
4.15 GBX
-0.0000000019 GBX (0.00%)
Last closed
4.15 GBX
Company
www.genincode.com
ISIN
unknown
Sector
Healthcare
Industry
Diagnostics & Research
Exchange
London Exchange
Capitalization
7 350 288 GBX
Yield for 12 month
-46.45 %
1Y
3Y
5Y
10Y
15Y
GENI
GENinCode Plc develops and commercializes clinical genetic tests to provide predictive analysis of risk to a patient's health based on their genes in the United Kingdom and internationally. Its predictive technology provides patients and physicians with preventative care and treatment strategies. The company's molecular tests combine clinical algorithms and artificial intelligence to provide advanced patient risk assessment to predict disease onset. Its tests include Cardio inCode, a patented genetic test to help user to adopt cardiovascular prevention steps; Lipid inCode, a genetic diagnostic test for familial hypercholesterolemia; SUDD inCode, a genetic test to diagnose the cause of sudden cardiac death and familial heart disease; Thrombo inCode, a genetic test for diagnosis of hereditary thrombophilia and the risk of thrombosis. In addition, the company offers Thrombo inCode Reproductive Health, a genetic test that offers information related to risk of thrombophilia and associated risks for future pregnancies. GENinCode Plc was incorporated in 2018 and is based in Manchester, the United Kingdom. Address: One St Peters Square, Manchester, United Kingdom, M2 3DE
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
2 085.96 GBXP/E ratio
–Dividend Yield
–Current Year
+216 185 770 GBX
Last Year
+143 123 026 GBX
Current Quarter
+69 509 744 GBX
Last Quarter
+69 509 744 GBX
Current Year
+67 157 714 GBX
Last Year
+63 254 351 GBX
Current Quarter
+36 531 411 GBX
Last Quarter
+36 531 411 GBX
Key Figures GENI
1 year
3 years
5 years
10 years
EBITDA
-5 771 993 GBX
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-63.99 %
PEG Ratio
–
Return On Equity TTM
-156.92 %
Wall Street Target Price
2 085.96 GBX
Revenue TTM
2 601 236 GBX
Book Value
0.016 GBX
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
46.2 %
Dividend Yield
–
Gross Profit TTM
593 510 GBX
Earnings per share
-0.05 GBX
Diluted Eps TTM
-0.05 GBX
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-228.7 %
Dividend Analytics GENI
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History GENI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation GENI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
1.7899
Price Sales TTM
2.8257
Enterprise Value EBITDA
-3.1541
Price Book MRQ
2.6098
Financials GENI
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators GENI
For 52 weeks
3.34 GBX
10.01 GBX
50 Day MA
5.72 GBX
Shares Short Prior Month
–
200 Day MA
6.16 GBX
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart